Ultragenyx (RARE) came out with a quarterly loss of $1.57 per share versus the Zacks Consensus Estimate of a loss of$1.54. This compares to loss of $2.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -1.95$1.24 per share when it actually produced a loss of $1.39, delivering a surprise of -12.10%.Over the last four quarters, the company ha ...